Delivery Order SPE2DX15D3012-SPE2DX24F8PY5
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is a Firm Fixed Price Delivery Order for a pharmaceutical product called LONSURF 15 MG-6.14 MG TABLET 40S. The award has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a Delivery Order valued at $9,583.44 issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999. The contract covers the procurement of the pharmaceutical product LONSURF 15 MG-6.14 MG TABLET 20S. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which has a period of performance...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,220.76, is a delivery order for the drug LONSURF 20 MG-8.19 MG TABLET 20S. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price instrument. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 40S. The contract has an ultimate completion date of April 4, 2025 and a firm fixed price pricing type. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999 Indefinite...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $19,198.52 firm fixed price delivery order contract to supply 60 tablets of the medication LONSURF 20 MG-8.19 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp, which serves as the prime contractor for providing pharmaceuticals and medical supplies to DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 20S. The contract has a ceiling value of $10,156.60 and a period of performance through April 8, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,599.25 fixed-price delivery order contract is for the provision of LONSURF 20 MG-8.19 MG TABLET 60S, a specialty pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication LONSURF 20 MG-8.19 MG TABLET 40S. The contract has a firm fixed price of $6,760.14 and an ultimate completion date of July 8, 2025. The contract is not set-aside and was awarded on June 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- SPE2DX15D3012Indefinite Delivery Contract
- SPE2DX15D3012-SPE2DX24F8PY5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product LONSURF 15 MG-6.14 MG TABLET 20S. The contract, valued at $7,187.58, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical under a Delivery Order contract with a firm fixed price pricing type. The contract has a completion date of July 2, 2024 and does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 6/10/24 |